| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 33.3% | 3/9 |
| Female | 66.7% | 6/9 |
| Indifferent | 0% | 0/9 |
| Unknown | 0% | 0/9 |
| General | ||
| 44.4% | 4/9 | |
| 55.6% | 5/9 | |
| Current Head circumference | 0% | 0/9 |
| 100% | 7/7 | |
| 100% | 9/9 | |
| 100% | 8/8 | |
| 85.7% | 6/7 | |
| Neurology | ||
| 55.6% | 5/9 | |
| 44.4% | 4/9 | |
| 22.2% | 2/9 | |
| Facial abnormalities | ||
| Abnormality of the ear | 0% | 0/9 |
| Abnormality of the eye | 0% | 0/9 |
| Abnormality of the nose | 0% | 0/9 |
| Abnormality of the mouth | 0% | 0/9 |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/9 |
| Abnormal vision | 0% | 0/9 |
| Heart | ||
| Abnormality of the heart | 0% | 0/9 |
| Gastrointestinal | ||
| Gastrointestinal | 0% | 0/9 |
| Urogenital | ||
| Urogenital | 0% | 0/9 |
| Skeleton | ||
| 22.2% | 2/9 | |
| Skin / Hair / Nails | ||
| Skin/Hair/Nails | 0% | 0/9 |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/9 |
| Metabolic | 0% | 0/9 |
| Immune | 0% | 0/9 |
| Neoplasia | ||
| Neoplasia | 0% | 0/9 |
MYT1L